Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey

Tekijä Steegmann, J. L., Sánchez Torres, J. M., Colomer, R., Vaz, Á., López, J., Jalón, I., Provencio, M., González-Martín, A., Pérez, M.
Julkaistu 2012

Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials

Tekijä le Coutre, P D, Hughes, T P, Mahon, F-X, Kim, D-W, Steegmann, J L, Shah, N P, Gooden, K, Wallis, N, Cortes, J E
Julkaisussa Leukemia (2016)

European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia

Tekijä Steegmann, J L, Baccarani, M, Breccia, M, Casado, L F, García-Gutiérrez, V, Hochhaus, A, Kim, D-W, Kim, T D, Khoury, H J, Le Coutre, P, Mayer, J, Milojkovic, D, Porkka, K, Rea, D, Rosti, G, Saussele, S, Hehlmann, R, Clark, R E
Julkaisussa Leukemia (2016)

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study

Tekijä Hochhaus, A, Rosti, G, Cross, N C P, Steegmann, J L, le Coutre, P, Ossenkoppele, G, Petrov, L, Masszi, T, Hellmann, A, Griskevicius, L, Wiktor-Jedrzejczak, W, Rea, D, Coriu, D, Brümmendorf, T H, Porkka, K, Saglio, G, Gastl, G, Müller, M C, Schuld, P, Di Matteo, P, Pellegrino, A, Dezzani, L, Mahon, F-X, Baccarani, M, Giles, F J
Julkaisussa Leukemia (2016)

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

Tekijä Hochhaus, A., Baccarani, M., Silver, R. T., Schiffer, C., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Deininger, M. W., Guilhot, F., Hjorth-Hansen, H., Hughes, T. P., Janssen, J. J. W. M., Kantarjian, H. M., Kim, D. W., Larson, R. A., Lipton, J. H., Mahon, F. X., Mayer, J., Nicolini, F., Niederwieser, D., Pane, F., Radich, J. P., Rea, D., Richter, J., Rosti, G., Rousselot, P., Saglio, G., Saußele, S., Soverini, S., Steegmann, J. L., Turkina, A., Zaritskey, A., Hehlmann, R.
Julkaisussa Leukemia (2020)

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure

Tekijä Hughes, T.P., Mauro, M.J., Cortes, J.E., Minami, H., Rea, D., DeAngelo, D.J., Breccia, M., Goh, Y.-T., Talpaz, M., Hochhaus, A., le Coutre, P., Ottmann, O., Heinrich, M.C., Steegmann, J.L., Deininger, M.W.N., Janssen, J.J.W.M., Mahon, F.-X., Minami, Y., Yeung, D., Ross, D.M., Tallman, M.S., Park, J.H., Druker, B.J., Hynds, D., Duan, Y., Meille, C., Hourcade-Potelleret, F., Vanasse, K.G., Lang, F., Kim, D.-W.
Julkaisussa N Engl J Med (2019)